University of Colorado Researchers Develop Experimental Drug to Reverse Osteoarthritis in Animals
Researchers at the University of Colorado (UC) Boulder have developed an experimental drug that has shown the potential to reverse osteoarthritis in animal models. Led by chemical and biological engineer Stephanie Bryant, the team has created a slow-release drug-delivery system that, when injected into damaged joints, encourages the body's own cartilage and bone cells to repair the damage. This development marks a significant step forward in osteoarthritis treatment, as current options are limited to pain management or joint replacement. The research, which is not yet peer-reviewed, aims to move into phase two, focusing on safety and toxicology, to lay the groundwork for human clinical trials. The team is also working on an injectable 'implant' to recruit the body's cells to repair cartilage gaps, offering potential solutions for different stages of osteoarthritis. 
